Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose amisulpride with an olanzapine-fluoxetine combination in post-schizophrenic depression has completed and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amisulpride (Solian) (Amisulpride)
  • Prozac (Fluoxetine) (Fluoxetine)
  • Zyprexa (Olanzapine) (Olanzapine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Post-Schizophrenic Depression | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19